A ranar 5 ga Janairu, 2021, Shangke Biopharmaceutical (Shanghai) Co., Ltd. an ba shi lambar yabo ta "(S) -1-tert-butoxycarbonyl-3-hydroxypiperidine" Babban aikin Canjin Nasara na Nasara na Shanghai.
A matsayinta na babbar sana’ar fasaha ta kasa, Suntech Biotech a kodayaushe tana daukar fasahar kere-kere don jagorantar ci gaban masana’antar sinadarai da magunguna, kuma tana kawo kore da lafiya ga bil’adama a matsayin manufarta.Don fadada kasuwancin ta hanyoyi da yawa, yin aiki tare da sanannun makarantu da masana'antu a gida da waje, ci gaba da haɓaka ƙarfin haɓaka nasa, inganta tsarin cikin gida na kasuwancin, kuma ya zama mafi kyau da ƙarfi.
Sunan aikin: (S) -1-tert-Butoxycarbonyl-3-hydroxypiperidine
Lambar Abu: 202010694
Matsayin abu: B
Ko akwai nasarori a fagen fasaha mai zurfi tare da 'yancin mallakar fasaha mai zaman kansa: Ee
Aikace-aikacen: (S) -1-tert-butoxycarbonyl-3-hydroxypiperidine (CAS: 143900-44-1) muhimmin matsakaicin chiral ne don haɗakar ibrutinib APIs.Ibrutinib wani sabon maganin ciwon daji ne wanda ke niyya ga cututtukan ƙwayoyin cuta na B-cell wanda aka amince da shi a ƙarƙashin ingantacciyar amincewa ta Hukumar Abinci da Magunguna ta Amurka (FDA) a ranar 13 ga Nuwamba, 2013 don maganin lymphoma.
Ma'anar babban canji na nasara na fasaha
Canjin nasarorin fasaha na fasaha yana nufin tsarin da kamfanoni ke samar da fasaha mai zurfi da aiki.Jiha tana tallafawa kamfanoni don aiwatar da sauyin nasarorin kimiyya da fasaha ta hanyar bincike da haɓaka masu zaman kansu, ba da lasisi, ɗaukar hannun jari akan farashi, da haɗin gwiwa tare da masana'antu, jami'o'i da cibiyoyin bincike.Don ayyukan sauye-sauye na ci gaba na fasaha da aka yi bitar kuma suka ba da rahoto, bisa ga kammala cikakkun alamun tattalin arziki da halayen haƙƙin mallaka na aikin, matakin ƙididdigewa, da sauransu, jarin R&D yana da alaƙa da aikin. Haƙƙoƙin mallaka masu alaƙa, takaddun shaida na ƙirƙira, ko waɗanda ke shiga ingantaccen matakin gwaji.Takaddun girmamawa da aka bayar ga kamfani bayan nazari mai zurfi da kuma cikakken bincike na kasuwa, kamar kayan hujja na aikace-aikacen haƙƙin ƙirƙira, takardar shaidar ƙirar ƙirar kayan aiki, takardar shaidar rajistar haƙƙin mallaka na software, takaddun rajistar ƙirar ƙirar ƙirar da'ira, da sauransu.
Bayanin Kamfanin
An kafa Shangke Biomedical (Shanghai) Co., Ltd a cikin 2008 kuma yana cikin filin shakatawa na kasa da kasa, yankin kudancin Zhangjiang Hi-Tech Park, Pudong, Shanghai.Wani reshe ne na Zhejiang Shangke Biomedical Co., Ltd. Shangke Bio ya himmatu wajen gudanar da bincike da bunkasuwar fannin harhada magunguna, yana jagorantar bunkasuwar masana'antar harhada magunguna tare da koren fasahar kere-kere, da samar da sabbin abubuwa. samfurori da ayyuka masu inganci don masana'antar harhada magunguna.Babban kamfani ne na fasaha a birnin Shanghai, haka kuma babbar sana'ar fasaha ce ta Shanghai "Masana'anta, mai ladabi, na musamman da sabo".
Babban kasuwancin Suntech ya haɗa da: haɓakawa da aikace-aikacen enzymes na halitta, haɓakawa da samar da matsakaicin magunguna, APIs da sinadarai masu aiki.Babban samfuran kamfanin sune samfuran coenzyme, gami da NMN, NAD, NADP, NADH, NADPH, enzymes na halitta, albarkatun magunguna da tsaka-tsaki.Abokan ciniki da abokan huldar kamfanin suna ko'ina a duniya, kuma sun kulla dangantakar hadin gwiwa tare da kamfanoni da yawa na magunguna a Arewacin Amurka, Turai, Indiya da China.
Lokacin aikawa: Janairu-15-2021